How the Product Works:
Activates GIP and GLP-1 receptors to increase insulin secretion
Lowers glucagon levels
Slows gastric emptying and reduces hunger
Promotes sustainable weight loss
Improves blood sugar control throughout the day
Recommended for:
Adults with type 2 diabetes
Patients with overweight or obesity
Those with inadequate glucose control on other therapies
Individuals with metabolic syndrome
Treatment of adult patients with type 2 diabetes mellitus to improve glycaemic control, alone or in combination with other antidiabetic medications.
Administer subcutaneously once weekly, with or without meals. Injection sites include the abdomen, thigh, or upper arm, alternating locations. Dosage and duration are determined by the healthcare provider.
Contraindications:
Hypersensitivity to any components
Type 1 diabetes mellitus
Severe renal or hepatic impairment
Children under 18
Pregnancy and breastfeeding
Side Effects:
Nausea, diarrhoea, vomiting
Loss of appetite
Injection site reactions
Hypoglycaemia (when combined with other therapies)
Possible headaches and constipation
